Clinical Study Class II on Ceram.x Universal and Prime&Bond

Clinical Post-Market Surveillance Study of Ceram.x Universal and Prime&Bond Universal When Used for Class II Restorations at the University of Sheffield

Damage to teeth from decay or previous old silver fillings can be repaired with tooth-coloured filling materials that stick to the tooth. These materials have been around for some years and have become more sophisticated; with greater ease of placement by the dentist and better durability for the patient. The fillings are designed to be used in combination with a specific glue (adhesive) that is designed to stick to the different parts of the tooth to provide a good seal, the outer enamel and the inner dentine.

This study will examine the performance of a state-of-the-art modern tooth coloured filling material (Ceram X) in combination with an existing adhesive (control adhesive) and a new adhesive (Prime & Bond Universal) used in two different techniques; both of which are known to work but one is easier to apply. This results in three treatment groups.

At the start of the study, the test material Prime&Bond Universal is CE-marked, as are all other medical devices used. Thus, this study is not conducted to meet any regulatory requirements. The rationale of this study is the extension of knowledge primarily concerning the clinical performance of Prime&Bond Universal in molars.

Two investigators (to be confirmed) will place a minimum of 25 restorations per group (75 restorations in total) to assess the performance of the materials in a comparative design. The study restorations will be monitored for a period of 18 months (with the option to extend the evaluation period to 48 months).

After placement of restorations under controlled clinical conditions, the primary objective of the study is the determination of post-operative sensitivity and pulp vitality, marginal adaptation and staining of margins of the restorations. In addition, fracture of material and retention, recurrent caries, occlusal contour and wear, approximal anatomical form will be determined as well as the failure rate as defined by the ADA.

Study Overview

Study Type

Interventional

Enrollment (Actual)

81

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • South Yorkshire
      • Sheffield, South Yorkshire, United Kingdom, S10 2TA
        • Professor Nicolas Martin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Inclusion criteria for patient selection:

  • Patients of either gender and at least 18 years old at the start of the study (enrollment), who are seeking treatment at the dental clinic involved, will be invited to participate in the study if they are in need of at least one eligible Class II posterior restoration in a permanent molar.

Tooth inclusion criteria:

  • Per patient, a maximum of three Class II restorations will be included. If three restorations are indicated and eligible, one of each material will be included.
  • Vital, non-symptomatic permanent teeth with Class II lesions are suitable for inclusion into the study if the following criteria are met:

    • - location: first or second molars (ADA guidelines[1]);
    • - restoration size: moderate: no cusp replacements;
    • - cavity size: occlusal width ≥ 1/3 of intercuspal distance (ADA guidelines[1]);
    • - cavity outline: preparation to include a proximal box with or without an occlusal step;
    • - box: cervical outline in enamel;
    • - occlusion: at least one opposing contact point in enamel.
  • Enrollment of patients will continue until the specified minimum number of restorations per group (N=25) and/or the minimum number of patients (N=50) have been reached.

Exclusion Criteria:

Exclusion criteria for patient selection:

  • The exclusion criteria (i.e. contraindications) as described in the Instructions for Use of the test, control and restorative materials apply:
  • Use with patients who have a history of severe allergic reaction methacrylate resins or any of the components; direct application to dental pulp (direct pulp capping).
  • Patients who are unable to give informed consent or vulnerable population as defined in ISO 14155[4] will not be enrolled.

Tooth exclusion criteria:

As a rule, the materials are not to be used in situations as specified in the Instructions for Use - Section Contraindications.

  • direct or indirect pulp-capping Furthermore, teeth with class II lesions are excluded when involved with
  • inflammation or pulpitis (pain),
  • periodontitis with probing depth > 6 mm,
  • extraction of tooth to be expected within the next 12 months,
  • signs of strong parafunctions or erosion (exposed dentin on occlusal surface and/or wear facets > 6 mm2)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: existing adhesive (control)
control adhesive
Control
Experimental: new adhesive: technique 1
Prime & Bond Universal: technique 1
Prime & Bond Universal
Experimental: new adhesive: technique 2
Prime & Bond Universal: technique 2
Prime & Bond Universal

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of participants with treatment-related postoperative sensitivity recorded as a change from baseline to that reported at 14 days, 6 months, 12 months and 48 months, assessed using a visual analog scale.
Time Frame: 14 days, 6 months, 12 months and 48 months
14 days, 6 months, 12 months and 48 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Nicolas Martin, Professor, Sheffield Teaching Hospitals NHS FT

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2015

Primary Completion (Actual)

March 31, 2022

Study Completion (Actual)

March 31, 2022

Study Registration Dates

First Submitted

December 4, 2015

First Submitted That Met QC Criteria

December 12, 2016

First Posted (Estimated)

December 13, 2016

Study Record Updates

Last Update Posted (Actual)

November 15, 2023

Last Update Submitted That Met QC Criteria

November 14, 2023

Last Verified

September 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • STH18842 CIP 14.1515

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Caries

Clinical Trials on Ceram X

3
Subscribe